TrialThe lancet. Diabetes & endocrinology2018

Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial.

Martin Schlumberger et al.PubMed ↗Publisher ↗

No numbers read from the abstract.